Flex Pharma (FLKS) Offers Regulatory, Clinical Update for FLX-787 for Treatment of Nocturnal Leg Cramp
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 5/27/2022
- Wall Street jumps on retailer outlook hikes, ebbing Fed fears
- Broadcom (AVGO) to Acquire VMware (VMW) for Approximately $61 Billion in Cash and Stock
- Ulta Beauty Shares Surge 8% on Q1 Beat and Raise
- NVIDIA (NVDA) Falls on Downbeat Guidance, Evercore ISI Remains a Buyer as Shares Trade Near an 'Estimated Floor of $150'
- After-Hours Stock Movers 05/26: Ulta, Dell Jump on Earnings; Gap, American Eagle Sink (more...)
- Wells Fargo (WFC) has fired dozens of loan officers accused of misusing appraisal waivers. Some say the bank gave them mixed signals - Business Insider
- Broadcom (AVGO) to Acquire VMware (VMW) for Approximately $61 Billion in Cash and Stock
- Wall Street jumps on retailer outlook hikes, ebbing Fed fears
- Kraft Heinz (KHC) Receives Notice of Partial Stock Distribution by 3G Capital
- 'His Personality Suggests Resolution Depends on Him Alone': Jefferies Discusses Elon Musk, Cuts PT on Tesla (TSLA) on Increased Risk Profile
- After-Hours Stock Movers 05/26: Ulta, Dell Jump on Earnings; Gap, American Eagle Sink (more...)
- Pre-Open Stock Movers 05/26: Retailers Dollar Tree, Macy's, and Williams-Sonoma Jump on Results; Nutanix, Snowflake, NVIDIA Fall (more...)
- After-Hours Stock Movers 05/25: NVIDIA, Snowflake Sink on Weaker Guidance; Williams-Sonoma Surges on Strong Numbers (more...)
- Pre-Open Stock Movers 05/25: Retailers Express, Nordstrom Gain Following Earnings; Verrica Pharma Sinks on FDA CRL (more...)
- Companies with NDRs 5/25
Flex Pharma Provides FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update
October 13, 2016 6:30 AM EDT-- Efficacy Signals Seen in Subanalyses of Exploratory Human Studies of FLX-787 --
-- Parallel Design Phase 2 Trial Planned for First Half 2017 Based upon FDA Pre-IND Responses --
-- Conference Call and Webcast today at 8:45 a.m. ET --
BOSTON--(BUSINESS WIRE)-- Click to Tweet
... More
Flex Pharma Provides FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update
October 13, 2016 6:30 AM EDT-- Efficacy Signals Seen in Subanalyses of Exploratory Human Studies of FLX-787 --
-- Parallel Design Phase 2 Trial Planned for First Half 2017 Based upon FDA Pre-IND Responses --
-- Conference Call and Webcast today at 8:45 a.m. ET --
BOSTON--(BUSINESS WIRE)-- Click to Tweet
... More
